Abstract:Background Patients with cancer can expect to receive numerous invasive vascular access procedures for intravenous therapy and clinical diagnostics. Due to the increased incidence and prevalence of cancer globally there will be significantly more people who require first-line intravenous chemotherapy over the next ten years. Methods Our objective was to determine the types of evidence that exist for the vascular access device (VAD) type for the delivery of systemic anti-cancer therapy (SACT) in cancer patients. We used JBI scoping review methodology to identify the types of VADs used for SACT and with a specific search strategy included articles from 2012-2022 published in the English language. We identify (i) type of VADs used for SACT delivery (ii) the type of insertion and post-insertion complications (iii) the geographical location and clinical environment (iv) and whether VAD choice impacts on quality of life (QOL). Findings were presented using the PAGER framework. Main findings Our search strategy identified 10,390 titles, of these, 5,318 duplicates were removed. The remaining 5072 sources were screened for eligibility, 240 articles met the inclusion criteria. The most common design include retrospective study designs (n=91) followed by prospective study designs (n=31). We found 28 interventional studies with 21 registered in a clinical trial registry and identified no core outcome sets papers specific to VAD for SACT. The most prevalent publications were those that featured two or more VAD types (n = 70), followed by tunnelled intravenous VADs (n = 67). Of 38 unique complications identified, the most frequent catheter related complication was catheter related thrombosis (n=178, 74%), followed by infection (n=170, 71%). The county where the most publications originated from was China (n=62) with one randomized controlled multicenter study from a comprehensive cancer centre. Of the thirty three studies that included QOL we found 4 which reported on body image. No QOL measurement tools specific to the process of SACT administration via VAD are available Interpretation Our findings suggest a systematic review and meta-analysis of VAD use for intravenous SACT can be considered. However, the development of a core outcome set for SACT should be prioritised. Funding for high quality programs of research for VAD in cancer are needed. Comprehensive cancer centres should lead this research agenda.

Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review

Patient reported outcome and experience measures among patients with central venous access devices: a systematic review

Vascular access device type for systemic anti-cancer therapies in cancer patients. A scoping review

Central venous access device adverse events in pediatric patients with cancer: a systematic review and meta-analysis

International experts consensus on optimal central vascular access device selection and management for patients with cancer

Central Venous Access Device–Associated Skin Complications in Adults with Cancer: A Prospective Observational Study

A scoping review of Clinical Studies, Hospital Group Reports and National Strategic Documents on vascular access devices in cancer patients

Complication Rates of Peripherally Inserted Central Catheters in Oncologic Versus Non-Oncologic Patients

Implementation frameworks, strategies and outcomes in optimizing central venous access device practice in paediatrics: A scoping review

Incidence and risk factors of complications during central venous access devices removal in children

Vascular access devices for prolonged intravenous therapy regimens in people diagnosed with cancer

Catheter-related complications in onco-hematologic children: A retrospective clinical study on 227 central venous access devices

Assessing the time-to-removal of totally implantable venous access devices comparing valved-versus open-ended catheters in patients treated with chemotherapy

Application of Implanted Central Venous Port Access System in Chemotherapy and the Nursing of Common Complications

The NAVIGATE project: A GloVANet–WoCoVA position statement on the nomenclature for vascular access devices

Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey

A Retrospective Cohort Study of Implantable Venous Access Port-Related and Peripherally Inserted Central Catheter-Related Complications in Patients with Hematological Malignancies in China

Central venous catheters-related-thrombosis and risk factors in oncological patients: A retrospective evaluation of recent risk scores

Catheter‐related thrombosis incidence and risk factors in adult cancer patients with central venous access devices

Systematic Review of the Safety and Efficacy of Central Vascular Access Device Securement

Results of a long-term, prospective study on complications of central venous catheter in pediatric patients with hematologic-oncologic diseases